Bond Covalency and Oxidation State of Actinide Ions Complexed with Therapeutic Chelating Agent 3,4,3-LI(1,2-HOPO). 2018

Morgan P Kelley, and Gauthier J-P Deblonde, and Jing Su, and Corwin H Booth, and Rebecca J Abergel, and Enrique R Batista, and Ping Yang
Theoretical Division , Los Alamos National Laboratory , Los Alamos , New Mexico 87544 , United States.

The hydroxypyridinone ligand 3,4,3-LI(1,2-HOPO) is a promising agent for biological decorporation of radionuclides, and allows spectroscopic detection of many lanthanide (Ln) and actinide (An) species via sensitized luminescence. Despite the manifest uses of this ligand, the structural and thermodynamic properties of its complexes across the An series remain understudied. Theoretical investigations of the binding of An(III) and An(IV) ions, from actinium to einsteinium, by the 3,4,3-LI(1,2-HOPO) ligand, as well as experimental extended X-ray absorption fine structure (EXAFS) studies on the trivalent americium, curium, and californium complexes were employed to address the resulting structures, thermodynamic parameters, redox properties, and corresponding electronic configurations. An(IV) ions were found to form much stronger complexes than An(III) ions, consistent with experimental measurements. Complexation of both An(III) and An(IV) ions generally becomes more favorable for heavier actinides, reflecting increased energy degeneracy driven covalency and concomitant orbital mixing between the 5f orbitals of the An ions and the π orbitals of the ligand. Notably, the ability of this ligand to either accept or donate electron density as needed from its pyridine rings is found to be key to its extraordinary stability across the actinide series.

UI MeSH Term Description Entries

Related Publications

Morgan P Kelley, and Gauthier J-P Deblonde, and Jing Su, and Corwin H Booth, and Rebecca J Abergel, and Enrique R Batista, and Ping Yang
May 2015, Journal of pharmaceutical sciences,
Morgan P Kelley, and Gauthier J-P Deblonde, and Jing Su, and Corwin H Booth, and Rebecca J Abergel, and Enrique R Batista, and Ping Yang
May 2015, Drug development research,
Morgan P Kelley, and Gauthier J-P Deblonde, and Jing Su, and Corwin H Booth, and Rebecca J Abergel, and Enrique R Batista, and Ping Yang
May 2023, The journal of physical chemistry. B,
Morgan P Kelley, and Gauthier J-P Deblonde, and Jing Su, and Corwin H Booth, and Rebecca J Abergel, and Enrique R Batista, and Ping Yang
November 2014, Journal of pharmaceutical and biomedical analysis,
Morgan P Kelley, and Gauthier J-P Deblonde, and Jing Su, and Corwin H Booth, and Rebecca J Abergel, and Enrique R Batista, and Ping Yang
January 2015, Journal of pharmaceutical and biomedical analysis,
Morgan P Kelley, and Gauthier J-P Deblonde, and Jing Su, and Corwin H Booth, and Rebecca J Abergel, and Enrique R Batista, and Ping Yang
June 2014, Journal of medicinal chemistry,
Morgan P Kelley, and Gauthier J-P Deblonde, and Jing Su, and Corwin H Booth, and Rebecca J Abergel, and Enrique R Batista, and Ping Yang
December 2018, Radiation protection dosimetry,
Morgan P Kelley, and Gauthier J-P Deblonde, and Jing Su, and Corwin H Booth, and Rebecca J Abergel, and Enrique R Batista, and Ping Yang
September 2010, Health physics,
Morgan P Kelley, and Gauthier J-P Deblonde, and Jing Su, and Corwin H Booth, and Rebecca J Abergel, and Enrique R Batista, and Ping Yang
August 2013, Inorganic chemistry,
Morgan P Kelley, and Gauthier J-P Deblonde, and Jing Su, and Corwin H Booth, and Rebecca J Abergel, and Enrique R Batista, and Ping Yang
June 2023, Chemico-biological interactions,
Copied contents to your clipboard!